MGP Ingredients Q1 net loss $134.8M on $179.5M non-cash impairments; adj. EPS $0.15

MGP INGREDIENTS INC

2026-Q1 EPS reported -$6.30 revenue$106,427,000

Revenue fell 13% to $106.4M; net loss of $134.8M ($6.30 basic loss) vs year-ago loss of $3.0M.
Recorded $115.7M goodwill and $37.0M indefinite-lived intangible impairments in Branded Spirits; also $26.9M fixed-asset impairment at Lux Row distillery.
Adjusted net income $3.3M (-57%), adjusted EBITDA $15.0M (-31%), adjusted basic EPS $0.15 (-58%).
Branded Spirits sales down 8% to $44.2M, but premium-plus up 1.5% (Penelope Bourbon +10%); Distilling Solutions down 40%.
Reaffirmed FY2026 guidance: sales $480-500M, adj. EBITDA $90-98M, adj. EPS $1.50-1.80; declared $0.12 quarterly dividend.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

MGP INGREDIENTS INC reported the first quarter ended March 31, 2026 results: revenue $106.4 million, net income $3.3 million, EPS $0.15 per share. Guidance reaffirmed.

Period: the first quarter ended March 31, 2026
Revenue: $106.4 million
Net income: $3.3 million
EPS: $0.15 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

growth, taking decisive actions, and executing with discipline.” First Quarter 2026 Financial Highlights Compared to First Quarter 2025: • Consolidated sales decreased 13% to $106.4 million. • Consolidated gross profit decreased 22% to $33.6 million. Gross margin decreased by 400 basis points to 31.6%. • Net income decreased to a loss of $134.8 million, primarily

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

MGP INGREDIENTS INC filing history →

Source: SEC EDGAR

accession 0000835011-26-000066

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.